PTHS Reports $16.2M ZELSUVMI Net Revenue, $16.8M Total Revenue, 129% QoQ Units, $18M Cash, $30M Term Loan
Pelthos Therapeutics Inc. · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $26.20
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS